Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Oct 29, 2014
Effective statin medications have been used to reduce cholesterol in heart disease patients for over 2 decades, but some people are intolerant and cannot benefit from them. Several PCSK9 inhibitors, or injectable cholesterol lowering drugs, are in development for those who don’t benefit from statins. The FDA is expected to approve the first PCSK9 in 2015 for its ability to significantly lower LDL cholesterol to levels never seen before.